BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 10310848)

  • 1. Trends in Medicare reimbursement for end-stage renal disease: 1974-1979.
    Eggers PW
    Health Care Financ Rev; 1984; 6(1):31-8. PubMed ID: 10310848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The first DRG: lessons from the end stage renal disease program for the prospective payment system.
    Maxwell JH; Sapolsky HM
    Inquiry; 1987; 24(1):57-67. PubMed ID: 2951335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The economics of home care for the treatment of end-stage renal failure.
    Ludbrook A
    Int J Technol Assess Health Care; 1985; 1(2):315-24. PubMed ID: 10311546
    [No Abstract]   [Full Text] [Related]  

  • 4. Medicare program; end-stage renal disease program; prospective reimbursement for dialysis services and approval of special purpose renal dialysis facilities--HCFA. Final rule.
    Fed Regist; 1983 May; 48(92):21254-91. PubMed ID: 10299129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Home dialysis costs less than outpatient dialysis.
    Blagg CR
    N Engl J Med; 1982 Feb; 306(7):431. PubMed ID: 7035952
    [No Abstract]   [Full Text] [Related]  

  • 6. The Medicare cost of renal dialysis. Evidence from a statistical cost function.
    Dor A; Held PJ; Pauly MV
    Med Care; 1992 Oct; 30(10):879-91. PubMed ID: 1405794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Home vs. in-center dialysis: reassessing the burdens.
    Schatell D
    Nephrol Nurs J; 2005; 32(3):347. PubMed ID: 16035476
    [No Abstract]   [Full Text] [Related]  

  • 8. Health policy report. Funding the End-Stage Renal-Disease Program.
    Iglehart JK
    N Engl J Med; 1982 Feb; 306(8):492-6. PubMed ID: 7035954
    [No Abstract]   [Full Text] [Related]  

  • 9. Self-care dialysis fits in with new economic challenges for providers.
    Usewicz MC
    Nephrol News Issues; 2011 Aug; 25(9):34-5. PubMed ID: 21905529
    [No Abstract]   [Full Text] [Related]  

  • 10. Management of end-stage renal disease in Alabama.
    Melnick S
    Ala J Med Sci; 1983 Oct; 20(4):456-9. PubMed ID: 6359945
    [No Abstract]   [Full Text] [Related]  

  • 11. Feds finalizing payment cuts for dialysis.
    Med World News; 1983 Apr; 24(8):27. PubMed ID: 10259563
    [No Abstract]   [Full Text] [Related]  

  • 12. Cost analysis of dialysis treatments for end-stage renal disease (ESRD).
    Goeree R; Manalich J; Grootendorst P; Beecroft ML; Churchill DN
    Clin Invest Med; 1995 Dec; 18(6):455-64. PubMed ID: 8714789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. If daily dialysis is the answer, what is the question?
    Rettig RA
    Am J Kidney Dis; 2001 Apr; 37(4):862-5. PubMed ID: 11273889
    [No Abstract]   [Full Text] [Related]  

  • 14. Carrier payment delays biggest problem for ESRD facilities.
    Paganini E
    Nephrol News Issues; 1990 Apr; 4(4):39-42. PubMed ID: 2333120
    [No Abstract]   [Full Text] [Related]  

  • 15. Cost savings of home nocturnal versus conventional in-center hemodialysis.
    McFarlane PA; Pierratos A; Redelmeier DA
    Kidney Int; 2002 Dec; 62(6):2216-22. PubMed ID: 12427148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cost of starting and maintaining a large home hemodialysis program.
    Komenda P; Copland M; Makwana J; Djurdjev O; Sood MM; Levin A
    Kidney Int; 2010 Jun; 77(11):1039-45. PubMed ID: 20375983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profits and the end-stage renal-disease program.
    N Engl J Med; 1982 Feb; 306(6):369-71. PubMed ID: 7054718
    [No Abstract]   [Full Text] [Related]  

  • 18. ESRD centers deserve a level playing field..
    Nidetz M
    Nephrol News Issues; 1989 Nov; 3(11):22-4. PubMed ID: 2594107
    [No Abstract]   [Full Text] [Related]  

  • 19. Systematic review of the effectiveness and cost-effectiveness, and economic evaluation, of home versus hospital or satellite unit haemodialysis for people with end-stage renal failure.
    Mowatt G; Vale L; Perez J; Wyness L; Fraser C; MacLeod A; Daly C; Stearns SC
    Health Technol Assess; 2003; 7(2):1-174. PubMed ID: 12773260
    [No Abstract]   [Full Text] [Related]  

  • 20. The case for daily dialysis: its impact on costs and quality of life.
    Mohr PE; Neumann PJ; Franco SJ; Marainen J; Lockridge R; Ting G
    Am J Kidney Dis; 2001 Apr; 37(4):777-89. PubMed ID: 11273878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.